Erbitux and Urinary tract infection - a phase IV clinical study of FDA data
Summary:
Urinary tract infection is reported as a side effect among people who take Erbitux (cetuximab), especially for people who are female, 60+ old, have been taking the drug for < 1 month also take Cisplatin, and have Colon cancer.
The phase IV clinical study analyzes which people have Urinary tract infection when taking Erbitux. It is created by eHealthMe based on reports of 19,227 people who have side effects when taking Erbitux from the FDA, and is updated regularly.
What is Erbitux?
Erbitux has active ingredients of cetuximab. It is often used in cancer. eHealthMe is studying from 19,276 Erbitux users. Check the latest studies of Erbitux.
What is Urinary tract infection?
Urinary tract infection is found to be associated with 3,014 drugs and 3,955 conditions by eHealthMe. Check the latest studies of Urinary tract infection.
19,227 people reported to have side effects when taking Erbitux.
Among them, 117 people (0.61%) have Urinary tract infection.
Among these 117 people:
How long have people been on Erbitux when they have Urinary tract infection? *
What is the gender of people who have Urinary tract infection when taking Erbitux? *
What is the age of people who have Urinary tract infection when taking Erbitux? *
What are other drugs people take besides Erbitux? *
What are other side effects people have besides Urinary tract infection? *
What are the existing conditions these people have? *
* Approximation only. Some reports may have incomplete information.
Do you take Erbitux and have Urinary tract infection?
- Check whether Urinary tract infection is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, long term effects of, and alternative drugs to Erbitux:
- Erbitux (19,276 reports)
Urinary tract infection treatments and more:
- Urinary tract infection (281,658 reports)
How severe was Urinary tract infection and when was it recovered:
Expand to all the drugs that have ingredients of cetuximab:
Sub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Erbitux:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all the drugs that are associated with Urinary tract infection:
- Urinary tract infection (3,014 drugs)
Browse all the conditions that are associated with Urinary tract infection:
- Urinary tract infection (3,955 conditions)
Related publications that referenced our studies
- Gupta D, Shukla P, Bisht SS, Bhatt ML, Pant MC, Srivastava K, "Deep vein and artery thrombosis associated with cetuximab-based chemoradiotherapy", Indian journal of pharmacology, 2011 Jan .
- Gupta D, Shukla P, Bisht SS, Bhatt ML, Pant MC, Srivastava K, "Deep vein and artery thrombosis associated with cetuximab-based chemoradiotherapy", Indian journal of pharmacology, 2011 Jan .
How the study uses the data?
The study uses data from the FDA. It is based on cetuximab (the active ingredients of Erbitux) and Erbitux (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Drug interactions of Celexa and Xyzal - a second ago
- Drug interactions of Advair Hfa and Fish Oil - 18 seconds ago
- Drug interactions of Olanzapine and Sandostatin Lar - 20 seconds ago
- Thyroid Diseases and Urinary Tract Infection - 25 seconds ago
- Could Bortezomib cause Anaemia? - 26 seconds ago
- Drug interactions of Guaifenesin and Lisinopril And Hydrochlorothiazide - 27 seconds ago
- Could Amnesteem cause Malaise? - 28 seconds ago
- Could Metformin cause Night Sweats? - 33 seconds ago
- Silenor vs. Amitriptyline Hydrochloride, side effect and effectiveness comparison - 38 seconds ago
- Could Sinemet cause Increased Tendency To Bruise? - 51 seconds ago